Intellectual Property News - Secerna LLP

Mrna Vaccines (1)

Beyond the Science: Five Intellectual Property Challenges Facing Thermostable Vaccine Developers

News IP Insights 23/08/2026

This article examines five intellectual property challenges that are likely to shape the long-term success of thermostable vaccine developers.

Read more

Copyright European Union. (1)

European, Industry news, News 22/10/2024

EU Council Approves Modernised Design Protection Package

AgriTech and Intellectual Property

Industry news, News 17/10/2024

AgriTech and Intellectual Property

Secerna Interior Shots September 2024 002

Industry news, News, Team news 08/10/2024

Secerna LLP Strengthens Chemistry & Pharmaceutical Team with New Patent Attorney

Mpox: Emerging Challenges and Pharmaceutical Innovations in the Face of a Global Health Crisis (Main)

Industry news, News 07/10/2024

Mpox: Emerging Challenges and Pharmaceutical Innovations in the Face of a Global Health Crisis

Navigating Employee Inventor Rights

Industry news, News 30/09/2024

Navigating Employee Inventor Rights

Secerna Highlights IP Importance on "Why Small Business Matters" Podcast

Events, Industry news, News 25/09/2024

Secerna Highlights IP Importance on "Why Small Business Matters" Podcast

Morning Sickness Drugs Repurposing

News 17/09/2024

Morning Sickness: The Role of Drug Repurposing and Intellectual Property Considerations

Charlotte Cell & Gene Meeting On The Mesa

Events, News 17/09/2024

Secerna to attend Cell & Gene Meeting on the Mesa in Phoenix, USA

John, Jon NEPIC

Events, News, Team news 17/09/2024

Secerna to attend NEPIC Meet the Members Expo 2024

18 19 20 21 22 23 24 25 26 27 28